Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: April 26, 2012
Reporting Period: First Quarter of 2012
This filing serves as a notification that the Company issued a press release announcing its financial results for the first quarter of 2012. The full details of the results are contained in the press release furnished as Exhibit 99.1 and supplemental information in Exhibit 99.2.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2).
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the announcement of Q1 2012 results.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. Such information is expected to be found in the referenced press release and supplemental exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2012 revenue, earnings per share, and net income figures.
- Examine Exhibit 99.2 for supplemental data not included in the main press release.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any updated full-year guidance or forward-looking statements in the referenced documents.